Surgical Resection of Hepatoblastoma: Factors Affecting Local Recurrence
Introduction This study aimed to investigate potential factors contributing to local recurrence after surgical resection of hepatoblastoma (HB).
Materials and Methods This retrospective study involving all patients with HB who underwent nontransplant surgery at our tertiary center between July 2007 and July 2018. Data were analyzed regarding microscopic surgical resection margin, tumor multifocality and extracapsular tumor extension in correlation with local recurrence. These relations were assessed by logistic regression.
Results The study included 133 patients with a median age of 1.3 years (range: 0.5–12.8 years). They were classified into 99 cases (74.44%) standard risk and 34 cases (25.56%) high risk. Delayed surgical resection was adopted in all patients. Follow-up to July 2019 revealed that 23 patients (23/133, 17.3%) developed local recurrence, whereas the remaining 110 were locally disease free. Microscopic positive margin (R1) was detected in 29 patients, 8 of them had local recurrence (p = 0.097). Regarding tumor multifocality, there were 12 patients who had multifocal lesions, 3 of them developed local recurrence (p = 0.459). Forty-four patients had extracapsular tumor extension in their pathological reports, 12 of them had local recurrence (p = 0.032).
Conclusion Extracapsular tumor extension was a significant prognostic factor of local recurrence after surgical resection of HB. R1 margin does not necessarily require a second resection, and it could achieve accepted results when combined with adjuvant platinum-based chemotherapy. However, patients who are not eligible for surgical resection must be transferred for primary transplantation to obtain favorable outcome.
Keywordshepatoblastoma - children - surgical resection - local recurrence - extracapsular tumor extension
Study design: All authors. Patients' management: All authors. Data collection: A.E. Data analysis: A.E. and G.A. Manuscript writing: A.E. Manuscript critical revision: A.E., A.Y., and G.A. All authors read and approved the final manuscript.
Eingereicht: 26. April 2020
Angenommen: 16. August 2020
Artikel online veröffentlicht:
19. September 2020
© 2020. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 Fuchs J, Seitz G, Handgretinger R, Warmann SW. Extended hepatic resection in advanced hepatoblastoma. Front Biosci (Elite Ed) 2012; 4 (04) 462-469
- 2 Horton JD, Lee S, Brown SR, Bader J, Meier DE. Survival trends in children with hepatoblastoma. Pediatr Surg Int 2009; 25 (05) 407-412
- 3 Czauderna P, Lopez-Terrada D, Hiyama E, Häberle B, Malogolowkin MH, Meyers RL. Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr 2014; 26 (01) 19-28
- 4 Maibach R, Roebuck D, Brugieres L. et al. Prognostic stratification for children with hepatoblastoma: the SIOPEL experience. Eur J Cancer 2012; 48 (10) 1543-1549
- 5 Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group. Pediatr Blood Cancer 2009; 53 (06) 1016-1022
- 6 Fonseca A, Gupta A, Shaikh F. et al. Extreme hepatic resections for the treatment of advanced hepatoblastoma: Are planned close margins an acceptable approach?. Pediatr Blood Cancer 2018; 65 (02) 1-6
- 7 Hamilton EC, Balogh J, Nguyen DT, Graviss EA, Heczey AA, Austin MT. Liver transplantation for primary hepatic malignancies of childhood: The UNOS experience. J Pediatr Surg 2017; DOI: 10.1016/j.jpedsurg.2017.10.035.
- 8 Trobaugh-Lotrario AD, Feusner JH. Relapsed hepatoblastoma. Pediatr Blood Cancer 2012; 59 (05) 813-817
- 9 Semeraro M, Branchereau S, Maibach R. et al. Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL). Eur J Cancer 2013; 49 (04) 915-922
- 10 Trobaugh-Lotrario AD, Meyers RL, Feusner JH. Outcomes of patients with relapsed hepatoblastoma enrolled on Children's Oncology Group (COG) phase I and II studies. J Pediatr Hematol Oncol 2016; 38 (03) 187-190
- 11 von Schweinitz D. Hepatoblastoma: recent developments in research and treatment. Semin Pediatr Surg 2012; 21 (01) 21-30
- 12 Haeberle B, Schweinitz Dv. Treatment of hepatoblastoma in the German cooperative pediatric liver tumor studies. Front Biosci (Elite Ed) 2012; 4: 493-498
- 13 Hishiki T, Matsunaga T, Sasaki F. et al. Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT. Pediatr Surg Int 2011; 27 (01) 1-8
- 14 Abdelahamid S, Khedr RA, El WakeelM. et al. Hepatoblastoma in developing countries; eight years of single centre experience. J Cancer Ther 2018; 9: 793-806
- 15 Shanmugam N, Scott JX, Kumar V. et al. Multidisciplinary management of hepatoblastoma in children: experience from a developing country. Pediatr Blood Cancer 2017; 64 (03) 1-6
- 16 Dicken BJ, Bigam DL, Lees GM. Association between surgical margins and long-term outcome in advanced hepatoblastoma. J Pediatr Surg 2004; 39 (05) 721-725
- 17 Fuchs J, Rydzynski J, Hecker H. German Cooperative Liver Tumour Studies HB 89 and HB 94. et al. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma--a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94. Eur J Pediatr Surg 2002; 12 (04) 255-261
- 18 Fuchs J, Rydzynski J, Von Schweinitz D. Study Committee of the Cooperative Pediatric Liver Tumor Study Hb 94 for the German Society for Pediatric Oncology and Hematology. et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 2002; 95 (01) 172-182
- 19 Czauderna P. Hepatoblastoma throughout SIOPEL trials - clinical lessons learnt. Front Biosci (Elite Ed) 2012; 4: 470-479
- 20 Aronson DC, Weeda VB, Maibach R. Childhood Liver Tumour Strategy Group (SIOPEL). et al. Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report. Eur J Cancer 2019; 106: 126-132
- 21 Lautz TB, Ben-Ami T, Tantemsapya N, Gosiengfiao Y, Superina RA. Successful nontransplant resection of POST-TEXT III and IV hepatoblastoma. Cancer 2011; 117 (09) 1976-1983
- 22 Fuchs J, Cavdar S, Blumenstock G. et al. POST-TEXT III and IV hepatoblastoma: extended hepatic resection avoids liver transplantation in selected cases. Ann Surg 2017; 266 (02) 318-323
- 23 Fahy AS, Shaikh F, Gerstle JT. Multifocal hepatoblastoma: what is the risk of recurrent disease in the remnant liver?. J Pediatr Surg 2019; 54 (05) 1035-1040
- 24 Qureshi SS, Bhagat M, Kembhavi S, Vora T, Ramadwar M, Talole S. PRETEXT II-III multifocal hepatoblastoma: significance of resection of satellite lesions irrespective of their disappearance after chemotherapy. Pediatr Surg Int 2015; 31 (06) 573-579
- 25 Saettini F, Conter V, Provenzi M. et al. Is multifocality a prognostic factor in childhood hepatoblastoma?. Pediatr Blood Cancer 2014; 61 (09) 1593-1597
- 26 Czauderna P, Haeberle B, Hiyama E. et al. The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. Eur J Cancer 2016; 52: 92-101
- 27 Towbin AJ, Meyers RL, Woodley H. et al. 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT). Pediatr Radiol 2018; 48 (04) 536-554
- 28 Kolbe AB, Podberesky DJ, Zhang B, Towbin AJ. The impact of hepatocyte phase imaging from infancy to young adulthood in patients with a known or suspected liver lesion. Pediatr Radiol 2015; 45 (03) 354-365
- 29 Ishak KG, Glunz PR. Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases. Cancer 1967; 20 (03) 396-422
- 30 Zimmermann A. Hepatoblastoma and the hepatoblastoma family of tumors. In: Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Switzerland: Springer, Cham; 2017: 357-393
- 31 Shen G, Wu L, Zhao J. et al. Clinical and pathological study of tumor border invasion - is narrow resection margin acceptable in hepatoblastoma surgery?. Front Med (Lausanne) 2020; 7: 59